Pricing Log in Create free account

AN2 Therapeutics, Inc. (ANTX) vs NervGen Pharma Corp. (NGEN)

AN2 Therapeutics, Inc. and NervGen Pharma Corp. are both Biotechnology companies. AN2 Therapeutics, Inc. and NervGen Pharma Corp. are of similar size ($150.9M and $143.1M). Across the 8 metrics below, AN2 Therapeutics, Inc. leads on 4 and NervGen Pharma Corp. on 4.

Valuation

Metric ANTX NGEN Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.36 3.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (26.75%) (17.89%) (32.88%)
Free cash flow yield (17.14%) (14.96%) (23.13%)

Profitability

Metric ANTX NGEN Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.12%) (94.85%) (51.96%)
Return on assets (46.06%) (40.66%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANTX NGEN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 32.56% (68.14%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANTX NGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.32 2.07 4.97
Net debt to EBITDA 1.48 0.95 1.01

Dividend

Metric ANTX NGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANTX NGEN Biotechnology median
Market cap 150.94m 143.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack